 | « Back to article | Print this article |
Zydus Cadila Healthcare on Monday said its net profit during 2003-04 increased by 86.68 per cent to Rs 143 crore (Rs 1,430 million) as against Rs 76.6 crore (Rs 766 million) in the previous year.
The company's turnover registered a 14.02 per cent growth at Rs 1,172.3 crore (Rs 11.72 billion) as compared to Rs 1,028.2 crore (Rs 10.28 billion) in 2002-03.
In the reported fiscal, the company registered a 12 per cent rise in domestic formulations sales, while exports jumped by 62 per cent, a company release said in New Delhi.
The company's board has recommended a dividend of 120 per cent.
During 2003-04, the company launched Zydus Pharmaceuticals Inc to cater to the formulation generic market and filed 12 ANDAs. It also acquired Alpharma France in the last fiscal and streamlined its operations at Zydus France SAS.
The company added 69 products to its portfolio during the year and had filed 31 patent applications in various research disciplines, it added.